In contrast with methotrexate and tumor necrosis factor inhibitor–treated rheumatoid arthritis, our findings show that RTX in AAV does significantly affect the autoreactive B cell pool composition by reducing the accumulation of autoreactive naive B cells, as occurs in belimumab-treated lupus patients. Here, TNF is linked to systemic lupus erythematosus.